Six science and technology innovators from across the United States will join the fifth cohort of Oak Ridge National Laboratory’s Innovation Crossroads program in June.
Researchers at Oak Ridge National Laboratory have developed a novel envelope system that diverts heat or coolness away from a building and stores it for future use.
A team of researchers at Oak Ridge National Laboratory has developed a method to detect and measure air leaking from a building’s walls and roof that is quicker, cheaper and less disruptive to occupants.
A research team led by Oak Ridge National Laboratory bioengineered a microbe to efficiently turn waste into itaconic acid, an industrial chemical used in plastics and paints.
Oak Ridge National Laboratory researchers, in collaboration with Cincinnati Inc., demonstrated the potential for using multimaterials and recycled composites in large-scale applications by 3D printing a mold that replicated a single facet of a
The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.
The U.S. Department of Energy’s Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program is seeking proposals for high-impact, computationally intensive research campaigns in a broad array of science, engineering and computer science domains.
A team of researchers at Oak Ridge National Laboratory and the University of Tennessee have developed a concrete mix that demonstrated high early strength within six hours of mixing, potentially doubling the production capacity for the precast industry.
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.